Cough, Cold, Flu and Allergy Remedies - US - April 2016
"US sales of cough, cold, flu, and allergy remedies grew substantially in 2015 largely due to the Rx-to-OTC switch of Flonase, a nasal allergy medication. A moderately severe flu season, coupled with a relatively ineffective flu vaccine, contributed to growth in the market. Households with children are a strong opportunity for brand marketers as these consumers have the highest incidence of illness and are likely to purchase the most remedies."
- Marissa Gilbert, Health and Wellness Analyst
This report discusses the following key topics:
Cold/sinus and cough/throat remedies fail to match allergy remedy growth rate
Rx remedies represent a sales threat
Only moderate interest in allergy patch; rubs not perceived as effective for colds